It is an RT-PCR technique for the determination of several hotspot EGFR mutations at the time of diagnosis and facilitates the evaluation of patients with NSCLC for EGFR-TKI therapy [7]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.